# Study of DS-8201a in Subjects With Advanced Solid Malignant Tumors

> **NCT02564900** · PHASE1 · COMPLETED · sponsor: **Daiichi Sankyo Co., Ltd.** · enrollment: 292 (actual)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** DS-8201a (DP1)
- **DRUG:** DS-8201a (DP2)
- **DRUG:** DS-8201a (DP)

## Key facts

- **NCT ID:** NCT02564900
- **Lead sponsor:** Daiichi Sankyo Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09-01
- **Primary completion:** 2019-02-01
- **Final completion:** 2023-12-22
- **Target enrollment:** 292 (ACTUAL)
- **Last updated:** 2024-01-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02564900

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02564900, "Study of DS-8201a in Subjects With Advanced Solid Malignant Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02564900. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*